← Eichor
Condition: Kidney Transplantation In Highly Sensitized Patients Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Kidney Transplantation In Highly Sensitized Patients

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
Phase 2 · 5 location(s) · Hansa Biopharma AB · NCT05753930Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)
Phase 1/Phase 2 · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT07607197CAR-T Cell Therapy for Desensitization in Kidney Transplantation
Phase 1 · 3 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06056102Immunological Reset to Allow Access to HLA Compatible Transplantation in Highly Sensitized Kidney Transplant Candidates
NA · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT06809075CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants
EARLY_Phase 1 · 1 location(s) · Tongji Hospital · NCT07350837
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.